Senti Biosciences Holdings, Inc.SNTI
What Senti Biosciences Holdings, Inc. does.
Unless the context otherwise requires, for purposes of this section, the terms “we,” “us,” “our,” “our Company,” “the Company” or “Senti” refer to Senti Biosciences, Inc. and its subsidiaries.
We are a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with our gene circuit platform technologies for patients living with incurable diseases. Our mission is to create a new generation of smarter medicines that outsmart complex diseases using novel and unprecedented approaches. To accomplish this mission, we have built a synthetic biology platform that we believe may enable us to program next-generation cell and gene therapies with gene circuits. These gene circuits, which we created from novel and proprietary combinations of DNA sequences, are designed to reprogram cells with biological logic to sense inputs, compute decisions and respond to their respective cellular environments. Using gene circuits, our product candidates are designed to precisely kill cancer cells, spare healthy cells, increase specificity to target cells and control the expression of drugs even after administration.
We are applying our gene circuit technologies to develop a pipeline of medicines that use chimeric antigen receptor (“CAR”) white blood cells with the goal of addressing major challenges and providing potentially lifesaving treatments for people living with cancer. Our lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (“NK”) cells to create CAR-NK cells outfitted with gene circuit technologies in several oncology indications with high unmet need.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $2.8M | $4.3M | $2.6M | $0 | $22,000 |
| Net income | — | -$55.3M | -$58.2M | -$71.1M | -$52.8M | -$61.4M |
| Free cash flow | — | -$40.2M | -$76.3M | -$64.4M | -$41.4M | -$43.6M |
More on SNTI.
- Senti Biosciences Holdings, Inc. summary
- Senti Biosciences Holdings, Inc. financial statements
- Senti Biosciences Holdings, Inc. key metrics
- Senti Biosciences Holdings, Inc. health scores and style box
- Senti Biosciences Holdings, Inc. earnings
- Senti Biosciences Holdings, Inc. dividends
- Senti Biosciences Holdings, Inc. valuation
- Senti Biosciences Holdings, Inc. ownership and insiders
- Senti Biosciences Holdings, Inc. peers
Figures from Senti Biosciences Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.